预计到 2030 年,癫痫药物市场规模将从 2022 年的 77 亿美元增长至 107 亿美元;预计 2022-2030 年复合年增长率为 4.1%。不断增长的研发 (R&D) 活动可能仍是市场的主要趋势。
癫痫药物市场分析
越来越多的针对癫痫药物的临床试验旨在开发创新药物,这将为未来几年的市场增长提供丰厚的机会。例如,梅奥诊所进行了一项临床试验,以研究“盐酸芬氟拉明口服溶液 (ZX008)”作为肌阵挛性无力性癫痫患儿辅助治疗的有效性和安全性。此外,癫痫病例发病率的上升加速了对抗癫痫药物的需求,将推动市场增长。例如,公司推出创新产品是 2020-2030 年期间市场大幅增长的重要因素。不断增加的研发 (R&D) 活动可能仍是市场的主要趋势。
癫痫药物市场概况
根据世卫组织的报告,全球每年约有500万人被确诊为癫痫患者。高收入国家每10万人中约有49人被确诊为癫痫患者,低收入国家则高达139人。世界卫生组织(WHO)报告进一步显示,癫痫占全球疾病负担的0.5%以上,自付医疗费用给家庭带来沉重负担。因此,癫痫病例的增加将在未来十年加速对抗癫痫药物的需求。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
癫痫药物市场:
复合年增长率(2022 - 2030 年)4.1%- 2022 年市场规模
77 亿美元 - 2030 年市场规模
107 亿美元
市场动态
- 癫痫病例发病率上升,抗癫痫药物需求增加,市场前景看好
- 不断增长的研发活动可能仍是市场的主要趋势
- 越来越多的癫痫药物临床试验提供了有利可图的市场机会
关键人物;主力;重要一员
- 联合银行
- 诺华公司
- 辉瑞
- 葛兰素史克
- 雅培
- 赛诺菲
- 住友制药公司
- 梯瓦制药
- 催化剂制药公司
- 阿尔肯实验室
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 第一代抗癫痫药物
- 第二代抗癫痫药物
- 第三代抗癫痫药物
- 医院药房
- 零售药店
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
癫痫药物市场驱动因素和机遇
癫痫病例发病率上升,抗癫痫药物需求增加,市场前景看好
根据世卫组织 2024 年发布的报告,全球约有 5000 万人患有癫痫,癫痫是最常见的神经系统疾病——癫痫发病率的上升导致全球医疗费用负担沉重。例如,据估计,600 万活动性癫痫患者每年花费超过 215 亿美元,尽管如此,很少有欧洲国家制定了管理癫痫病的国家计划。因此,对抗癫痫药物的需求很高,以预防癫痫发作。例如,根据世卫组织的报告,多达 70% 的癫痫患者可以通过适当使用抗癫痫药物摆脱癫痫发作。此外,癫痫病例患病率的上升加速了对抗癫痫药物的需求,是全球癫痫药物市场份额的主要驱动力。
越来越多的癫痫药物临床试验提供了有利可图的市场机会
例如,Équilibre Biopharmaceuticals 的“EQU-001”见证了“阶段转变成功率 (PTSR)”,该公司报告了抗癫痫药物的第 2 阶段结果。此外,SANAD 临床试验旨在确定最有效和最具成本效益的癫痫患者治疗方法。此前,“丙戊酸”被批准用于控制癫痫发作,比“拉莫三嗪”更有效,是许多患有全身性和未分类癫痫患者的首选药物。然而,由于丙戊酸在怀孕期间的不良反应,医生停止开这种药。此外,拉莫三嗪通过临床试验被证明比丙戊酸更好,对于被诊断为部分性癫痫发作的患者来说是一种具有成本效益的替代方案。此外,2024 年,新抗癫痫药物临床试验 SANAD-2 的结果尚未公布。因此,越来越多的用于开发新型抗癫痫药物的临床试验将对市场产生积极影响,因为这为创新药物提供了机会。
癫痫药物市场报告细分分析
有助于得出癫痫药物市场分析的关键部分是类型、原因、疾病类型、类别和最终用户。
- 根据治疗,癫痫药物市场分为第一代抗癫痫药物、第二代抗癫痫药物、第三代抗癫痫药物。第二代抗癫痫药物在 2022 年占据了最大的市场份额。
- 根据分销渠道,市场分为医院药房、零售药房和其他。医院药房部门在 2022 年占据了最大的市场份额。
癫痫药物市场份额按地区分析
癫痫药物市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
北美占据了市场主导地位。在北美地区,美国占癫痫药物市场的最大份额。该地区顶级制造商的存在及其具有有效药理活性的创新抗癫痫药物是导致市场主导地位的因素。预计亚太地区将在未来几年以最高的复合年增长率增长。
癫痫药物市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 77亿美元 |
2030 年的市场规模 | 107亿美元 |
全球复合年增长率(2022 - 2030 年) | 4.1% |
历史数据 | 2020-2021 |
预测期 | 2022-2030 |
涵盖的领域 | 按治疗
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
癫痫药物市场新闻和最新发展
通过收集主要和次要研究后的定性和定量数据来评估癫痫药物市场,其中包括重要的公司出版物、协会数据和数据库。癫痫药物市场的一些发展如下所列:
- 卫材株式会社宣布推出用于静脉 (IV) 输液的新产品“Fycompa”。Fycompa 的注射剂型于 2024 年 1 月获得制造和营销批准,并于今日被列入日本国民健康保险 (NHI) 药品价格清单。Fycompa 是卫材筑波研究实验室发现的同类首创抗癫痫药。(来源:卫材株式会社,新闻稿,2024 年 4 月)
癫痫药物市场报告覆盖范围和交付成果
“癫痫药物市场规模和预测(2020-2030 年)”报告对以下领域进行了详细的市场分析:
- 癫痫药物市场规模及全球、区域和国家层面所有主要细分市场的预测
- 癫痫药物市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 癫痫药物市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及癫痫药物市场的最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The estimated value of epilepsy drugs market accounted US$ 11.9 billion in 2031.
UCB SA, Novartis AG, Pfizer, GSK, Abbott, Sanofi, Sumito Pharma Company, Teva Pharmaceuticals, Catalyst Pharmaceuticals, and Alkem Laboratories are the key players in the epilepsy drugs market.
Rising Research & Development (R&D) activities to remain as a key trend for epilepsy drugs market.
Rising incidence of epilepsy cases accelerate demand for antiepileptic drugs is one of the most influential factors responsible for market growth.
North America region dominated the epilepsy drugs market in 2023.
The CAGR for epilepsy drugs accounted 4.5% during 2023-2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.